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Objective: To determine the existence of cross-reactions between Leishmania serology and mycobacteriosis in 
patients infected with HIV-1. 
Patients and methods: HIV-positive individuals, with culture-proven episodes of tuberculosis or disseminated Myco- 
bacterium avium complex (MAC) infection, were identified from the data files of our microbiology laboratory. Patients 
were included if leishmania serology had been performed within a period of 2 months before and 1 month after the 
diagnosis of mycobacterial disease. 
Results: We identified 106 cases of tuberculosis and 38 of disseminated MAC infection with concomitant leishmania 
serology in HIV-infected individuals. Among them, only two cases (1.8%), both with tuberculosis and without visceral 
leishmaniasis, showed positive leishmania serology. The two cases are discussed. 
Conclusions: We conclude that, in spite of its low sensitivity, serology is a useful diagnostic tool in co-infected patients, 
mainly because of its high specificity and the low rate of cross-reactivity with two of the most frequent causes of fever 
of unknown origin in HIV-positive patients from our area. 
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INTRODUCTION 
Patients infected by HIV suffer from multiple oppor- 
tunistic infections, mainly when their CD4 lymphocyte 
count is very low. Among them, visceral leishmaniasis 
(VL), tuberculosis and disseininated Mycobacteuium 
uvium complex (MAC) infection are recognized causes 
of fever of unknown origin in our area [I]. Immuno- 
suppression very often precludes the normal host 
response to these pathogens, making diagnosis more 
difficult. As a consequence, patients are subjected to 
aggressive diagnostic techniques which result in much 
suffering and great expense. 
Serology is generally the first diagnostic approach 
in the detection of VL, indirect immunofluorescence 
assay (IFA) being the technique most frequently used. 
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Although the sensitivity of serology in HIV-positive 
patients is less than 60% [2,3], it remains a useful test, 
given its non-invasive character and high specificity 
(99%) [4]. However, cross-reactions with tuberculosis 
have been described, ranging from 0.95% [4], to 20% 
[5] and 33% 161. This could interfere with diagnosis, 
mainly in the initial stages of disease, thereby diminish- 
ing the usefulness of serology. Given that there is a high 
prevalence of tuberculosis in our area, and disseminated 
MAC infection is increasing, we evaluated the existence 
of such cross-reactions in HIV-positive individuals with 
mycobacteriosis. 
PATIENTS AND METHODS 
Our  institution is a tertiary-care teaching hospital 
which serves a population of 650000 inhabitants 
with a high prevalence of tuberculosis. HIV-positive 
individuals with culture-proven episodes of tuberculosis 
or disseminated MAC infection were identified from 
the data files of our microbiology laboratory, from 
September 1992 to December 1995. Patients were 
included in the study if leishmania serology had been 
performed within a period of 2 months before and 1 
month after the diagnosis of mycobacterial disease. 
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Leishmania serology was performed by IFA using 
a commercial kit (MarDx Diagnostics, Inc., Carlsbad, 
California, USA). The antigen preparation consisted of 
promastigotes of L. tropica, which had been cultured in 
a modification of the NNN medium. Titers greater 
than or equal to 1/80 were considered positive. 
RESULTS 
From 1992 to 1995, 822 cases of tuberculosis (281 
HIV positive/541 HIV negative) and 130 cases of 
disseminated MAC infection (1 18 HIV positive/l2 
HIV negative) were diagnosed at our hospital. In the 
same period, 35 episodes of parasitologically proven VL 
were diagnosed. The VL episodes correspond to first 
episodes and relapses, mainly in HIV-positive patients. 
The sensitivity of IFA in these cases was 45.7% (16/35). 
We identified 106 cases of tuberculosis and 38 
of disseminated MAC infection with concomitant 
leishmania serology in HIV-infected individuals. 
Among them, only two cases, both with tuberculosis, 
had positive leishmania serology. 
Patient 1, a 31-year-old, HIV-positive (B2 cate- 
gory) male, was admitted in July 1993 with a 20- 
day history of constitutional symptoms, fever, chills, 
dyspnea and weight loss. On examination, the patient 
appeared cachectic and dyspneic, and had hepato- 
splenomegaly. There was moderate anemia and a CD4+ 
T-cell count of 365 mm3. Chest X-ray revealed a 
bilateral interstitial infiltrate. Treatment was begun with 
antituberculous drugs and co-trimoxazole. A bone 
marrow sample showed necrotizing epithelioid granu- 
lomata, and 40 days after admission M.  tuberculosis was 
grown from urine. Leishmania serology was 1/160, but 
neither bone marrow microscopy nor parasite culture 
were positive. The patient was not compliant with 
treatment and was readmitted four times because of 
relapsing tuberculosis. On the last admission, progres- 
sive multifocal leukoencephalopathy was diagnosed and 
the patient died. On each of the four admissions, the 
leishmania serology remained positive (1/160, 1/80, 
1/320 and 1/320), but two additional bone marrow 
examinations did not show any parasites. 
Patient 2, a 26-year-old, HIV-positive (A2 category) 
male, was admitted in August 1994 with a 1-month 
history of cough, fever and yellowish sputum. He was 
febrile (38.6OC) and had some lymph nodes less 
than 1 cm in diameter and hepatomegaly. Analytic 
data disclosed leukopenia (2800 x 106/L), hemoglobin 
140 g/L, and platelets 118000x106/L, and a slight 
elevation of hepatic enzymes (aspartate aminotrans- 
ferase 71 IU, alanine aminotransferase 66 IU). The 
chest X-ray on admission showed bilateral interstitial 
infiltrates, and sputum showed acid-fast bacilli. The 
patient began antituberculous treatment. In spite of 
positive leishmania serology (1 / 160), samples for 
parasitology were not taken, as the patient improved 
with treatment. Over the next 5 months the patient was 
readmitted twice because of multiresistant tuberculosis, 
dying in a very poor general state in January 1995. On 
both admissions, the leishmania serology remained 
positive (1/160). However, given the patient’s poor 
general state of health, the presence of sputum smear- 
positive active tuberculosis and the absence of viscero- 
megaly and pancytopenia, bone marrow examination 
was not performed. 
DISCUSSION 
Tuberculosis, Chagas’ disease and malaria are conditions 
known to produce cross-reactions with leishmania 
serology when the IFA test is used [4-61. Furthermore, 
in the past, antigens prepared from mycobacteria 
(Mycobacteriurn pheli, Kedrowsky’s bacillus, and BCG) 
had been used in the complement-fixation test [6,7]. 
The cross-reactivity seen with the IFA test can be 
eliminated with the use of amastigotes instead of fixed 
promastigotes as the antigenic substrate [8]. 
Given that serology is usually the first stage in the 
laboratory diagnosis of VL and the high prevalence of 
tuberculosis in our area, we investigated the possibility 
of a high rate of cross-reaction in HIV-positive indi- 
viduals. We examined this issue because the clinical 
picture of VL in HIV-co-infected patients does not 
differ substantially from tuberculosis or disseminated 
MAC infections in the early stages. These are the three 
most common causes of fever of unknown origin in 
our area [l]. 
We could identify only two cases (1.8%) with 
positive leishmania serology among 106 HIV-positive 
individuals with tuberculosis. This cross-reactivity rate 
is slightly higher than that reported by Gallardo et al 
[4]. None of the 38 patients with disseminated MAC 
infection showed a positive serologic result. Patient 1 
may have suffered from asymptomatic VL in the past 
which had not relapsed clinically [9]. Nevertheless, 
given the high relapse rate of VL (60.7% in the first 
year) in HIV-positive individuals [lo], it seems im- 
probable that three bone marrow examinations were 
negative in the presence of a compatible clinical picture. 
Although, in patient 2 VL cannot be firmly excluded, 
the clinical picture and outcome could be explained by 
multiresistant tuberculosis, serology being the only 
support for a diagnosis. It is worth noting that both 
patients with repeated positive serology suffered from 
active tuberculosis when samples were taken. 
We conclude that, in spite of its low sensitivity, 
serology (IFA) is a useful diagnostic tool in HIV- 
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positive patients with VL, mainly because of its high 
specificity and the low rate of cross-reactivity with two 
of the most frequent causes of fever of unknown origin 
in HIV-infected individuals from our area. 
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